(2026). Sestrin-2: A new biomarker for type 2 Diabetes Mellitus and Insulin resistance. Journal of Diabetes and Metabolic Disorders.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Sestrin-2: A New Biomarker for Type 2 Diabetes Mellitus and Insulin Resistance."
Journal of Diabetes and Metabolic Disorders 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Sestrin-2: A New Biomarker for Type 2 Diabetes Mellitus and Insulin Resistance."
Journal of Diabetes and Metabolic Disorders, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.